J P Morgan Chase & Co reaffirmed their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a research note released on Thursday, November 2nd. J P Morgan Chase & Co currently has a target price on the healthcare company’s stock.
A number of other research analysts also recently issued reports on the company. Berenberg Bank set a CHF 260 price target on Roche Holding and gave the stock a neutral rating in a research note on Tuesday, October 24th. Morgan Stanley set a CHF 260 price target on Roche Holding and gave the stock a neutral rating in a research note on Friday, October 20th. Kepler Capital Markets set a CHF 226 price target on Roche Holding and gave the stock a neutral rating in a research note on Friday, October 20th. Deutsche Bank AG set a CHF 254 price objective on Roche Holding and gave the stock a neutral rating in a research report on Friday, October 20th. Finally, set a CHF 203 price objective on Roche Holding and gave the stock a sell rating in a research report on Friday, October 20th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of CHF 260.76.
Roche Holding (VTX ROG) traded up CHF 0.40 during trading hours on Thursday, reaching CHF 244. The company had a trading volume of 1,820,000 shares, compared to its average volume of 1,680,000. Roche Holding has a 12-month low of CHF 218.30 and a 12-month high of CHF 273.
WARNING: This article was originally reported by BBNS and is owned by of BBNS. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://baseballnewssource.com/markets/roche-holding-ltd-rog-rating-reiterated-by-j-p-morgan-chase-co-2/1750019.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with our FREE daily email newsletter.